Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Analog Devices | ADI | Sep 27, 2024 | 232.05 | -0.18 |
AnaptysBio | ANAB | Sep 27, 2024 | 31.87 | -1.97 |
Anavex Life Sciences | AVXL | Sep 27, 2024 | 5.68 | +0.18 |
Andretti Acquisition II Unit | POLEU | Sep 27, 2024 | 10.00 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Sep 27, 2024 | 2.05 | +4.59 |
ANEW Medical | WENA | Sep 27, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Sep 27, 2024 | 13.09 | 0.00 |
Angel Oak Mortgage REIT | AOMR | Sep 27, 2024 | 10.33 | +0.49 |
Anghami | ANGH | Sep 27, 2024 | 0.84 | -2.23 |
Angi A | ANGI | Sep 27, 2024 | 2.60 | -3.35 |
AngioDynamics | ANGO | Sep 27, 2024 | 7.66 | +2.00 |
Anglogold Ashanti | AU | Sep 27, 2024 | 27.67 | -5.04 |
Anheuser-Busch InBev ADR | BUD | Sep 27, 2024 | 65.99 | +0.72 |
ANI Pharmaceuticals | ANIP | Sep 27, 2024 | 58.78 | +0.82 |
Anika Therapeutics | ANIK | Sep 27, 2024 | 24.56 | -0.28 |
Anixa Biosciences | ANIX | Sep 27, 2024 | 3.19 | +0.31 |
Annaly Capital Management | NLY | Sep 27, 2024 | 20.66 | +1.27 |
Annaly Capital Management F Pref | NLY-F | Sep 27, 2024 | 25.51 | +0.28 |
Annaly Capital Management G Pref | NLY-G | Sep 27, 2024 | 25.22 | -0.16 |
Annaly Capital Management I Pref | NLY-I | Sep 27, 2024 | 25.66 | -0.04 |
Annexon | ANNX | Sep 27, 2024 | 6.14 | +0.33 |
Annovis Bio | ANVS | Sep 27, 2024 | 8.10 | -1.70 |
ANSYS | ANSS | Sep 27, 2024 | 325.15 | +0.10 |
Antelope Enterprise | AEHL | Sep 27, 2024 | 0.81 | -1.37 |
Anterix | ATEX | Sep 27, 2024 | 38.28 | +0.08 |
Antero Midstream | AM | Sep 27, 2024 | 15.01 | -0.07 |
Antero Resources | AR | Sep 27, 2024 | 28.71 | +3.61 |
Anywhere Real Estate | HOUS | Sep 27, 2024 | 5.11 | -2.29 |
Aon | AON | Sep 27, 2024 | 347.67 | +0.15 |
APA | APA | Sep 27, 2024 | 24.53 | +5.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.